Dr Lal Pathlabs Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
509.00
492.00
362.00
241.00
350.00
296.00
Adjustment
274.00
239.00
269.00
285.00
243.00
166.00
Changes In working Capital
26.00
1.00
35.00
35.00
-16.00
36.00
Cash Flow after changes in Working Capital
810.00
732.00
667.00
562.00
576.00
499.00
Cash Flow from Operating Activities
635.00
568.00
535.00
456.00
446.00
398.00
Cash Flow from Investing Activities
-421.00
-303.00
-24.00
-287.00
-449.00
-212.00
Cash Flow from Financing Activities
-263.00
-334.00
-413.00
-283.00
136.00
-138.00
Net Cash Inflow / Outflow
-49.00
-68.00
97.00
-114.00
133.00
47.00
Opening Cash & Cash Equivalents
292.00
360.00
263.00
378.00
244.00
196.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
242.00
292.00
360.00
263.00
378.00
244.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Dr Lal Pathlabs
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
509.75
344.27
165.00
48.07%
Adjustment
274.62
36.77
238.00
646.86%
Changes In working Capital
26.62
-40.66
66.00
165.47%
Cash Flow after changes in Working Capital
810.99
340.38
470.00
138.26%
Cash Flow from Operating Activities
635.61
266.08
369.00
138.88%
Cash Flow from Investing Activities
-421.86
-240.94
-181.00
-75.09%
Cash Flow from Financing Activities
-263.57
-20.15
-243.00
-1208.04%
Net Cash Inflow / Outflow
-49.83
4.99
-53.00
-1098.60%
Opening Cash & Cash Equivalents
292.63
7.06
285.00
4044.90%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
242.8
12.05
230.00
1914.94%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 11.73% vs 6.27% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
635.61
568.89
11.73%






